Oragenics Inc.

Oragenics Inc.
Stock Exchange NYSE
EPS
$0.93
Market Cap
$22.1 M
Shares Outstanding
46.13 M
Public Float
25.69 M

Profile

Address
4902 Eisenhower boulevard
Tampa Florida 33634
United States
Employees -
Website http://www.oragenics.com
Updated 07/08/2019
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D.

Financials

View All
Created with Highcharts 5.0.14Oragenics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.16 06816 0685 7895 78911 84011 8408 4978 4976 7316 7319 9149 91420132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14Oragenics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1 0321 0329399390000003030201320142015201620172018025050075010001250

Alan F. Joslyn
President, Chief Executive Officer & Director
Robert C. Koski
Director